Procurement of Drugs Used For Central Nervous System (Annual Requirement) MHPQ - Pharm - 2022-2023 - Q 37 Oib-Health - Ifb - 2022 - 928

Government of Mauritius e-Procurement System

Invitation for Bid Name: PROCUREMENT OF DRUGS USED FOR CENTRAL NERVOUS SYSTEM (ANNUAL
REQUIREMENT) MHPQ/PHARM/2022-2023/Q 37 OIB
Invitation for Bid NO.: HEALTH/IFB/2022/928
BIDDING DOCUMENTS
Bidding Documents: Procurement of Drugs used for Central Nervous System (Annual
Requirements).doc; Q 37 New Excel.xlsx
Guidelines for Suppliers on e-Procurement System: Guidelines for Suppliers on the use
of e-Procurement System_upto Award.pdf
Drawing(s): No files attached.
Site Plan: No files attached.
BID DOCUMENT FEE PAYMENT
Payment Status: No Payment Found
CANCELLATION REMARKS
Cancellation Remarks:
Supporting Document: No files attached.
COMPARATIVE STATEMENT FOR SUPPLIER
IFB ATTRIBUTES
Procurement Description: PROCUREMENT OF DRUGS USED FOR CENTRAL
NERVOUS SYSTEM (ANNUAL REQUIREMENT)
MHPQ/PHARM/2022-2023/Q 37 OIB
Nature of procurement: Normal procurement
Procurement Category: Goods
Procurement sub-category: Goods - Pharmaceutical articles
Procurement Open International
Method: Bidding
Procurement Request reference: MHPQ/PHARM/2022-2023/Q 37 OIB

Framework Agreement reference:
Source of Funding: Government of Mauritius
Allowed currency(ies): Mauritian Rupee,British Pound,Euro,South
African Rand,US Dollar
Bid Submission Fees: No Payment
Validity of Bids: 120 DAYS

Type of Security: None
Duration of Contract: AS PER SECTION IV SPECIAL CONDITION OF
CONTRACT GCC CLAUSE 11
Technical / Commercial Evaluation Mode: Technical and Commercial Normal Evaluation
PROJECT BRIEF
Project Brief:
PROCUREMENT OF DRUGS USED FOR CENTRAL NERVOUS SYSTEM(ANNUAL REQUIREMENT)

Procurement Reference: MHPQ/PHARM/2022-2023/Q 37 OIB
e- Procurement Reference: HEALTH/IFB/2022/928
REMARKS FOR CANCELLATION AUTHORITY

Remarks for Cancellation Authority:
SUSPENSION REMARKS
Remarks for Suspension:
Page 1 of 243
TECHNICAL CRITERIA FOR EVALUATION

Technical Criteria:
Sr. No. Technical Bidder Deviation, if Reference in
Criteria Response any bid response
1.1 The product
proposed must
meet all the
technical
specification
defined in
section VI of
the Bidding
Document and
to upload all
necessary
documents
when filling the
specification
compliace
sheet .
1.2 Bidders are
reqested to
download excel
"Q 37 New
Excel.xlsx"
attached along
with the
bidding
document
scan,fill and
upload in
Technical
Responsivenes
s
Checklist_Uplo
ad Template
on
eProcurement
System.
ELIGIBILITY & CONFLICT OF INTEREST CRITERIA FOR EVALUATION
Eligibility & Conflict of Interest Criteria for evaluation:
Sr. No. Mandatory Bidder Comments from Supporting
Criteria Response Bidder document
1.1 To be eligible
for this tender
Bidders must
submit proof of
registration
with one of the
drug regulatory
authorities at
ITB 6.2 , a
valid COPP for
products
quoted and of
package insert.
Page 2 of 243
1 Documents to
be uploaded :
Manufacturers
from Non PIC
countires must
have a valid
GMP
certificatefor
the
manufacturing
site where the
product on
tender are
being
manufactured
from either
EUDRA or
USFDA or
WHOPIR
2 Documents to
be uploaded :
Proof that
manufacturer is
incorporated in
country of
manufacture .
3 Documents to
be uploaded :
Proof that the
manufacturer is
licenced by the
regulatory
authority in the
country of
manufacture to
manufacture
and supply the
Goods .22
4 Documents to
be uploaded :
Proof that the
manufacturer
has
manufactured
and marketed
the goods on
tender for at
least two (2)
years .
Page 3 of 243
5 A written
declaration to
be uploaded
from the
manufacturers
or their
accredited
agents stating
whether they
have been
debarred
/disqualified
/banned from
supply by any
agency ( local
and overseas)
during the last
ten years . In
case they have
been debarred
/disqulified
/banned ,
provide name
of agency ,
period of
ineligibility and
reasons for
debarment /
disqualification.
2.1 Accredited
Pharmacy
Wholesalers
should be
either local
pharmacy
wholesalers
duly registered
with the
Pharmacy
Board of
Mauritius or
International
Pharmacy
wholesalers
duly registered
in PIC
countries. The
latter will have
to produce
evidence of
registration
near the DRA
of the country
of practice .
Page 4 of 243
2.2 Documents to
be uploaded :
Manufacturers
from Non PIC
countries must
have a valid
GMP certificate
for he
manufacturring
site where the
Vaccines and
Immunoglobulli
n on tender are
being
manufactured
from either
EUDRA or
USFDA or
WHOPIR
2.3 Documents to
be uploaded :
Proof that
manufacturer is
incorporated in
country of
manufacture ,
proof of WHO
pre-
qualification or
proof of
registration
with one of the
drug regulatory
authorities.
2.4 Documents to
be uploaded:
Proof that the
manufacturer is
licenced by the
regulatory
authority in the
country of
manufacture
to manufactute
and supply the
Goods .
2.5 Documents to
be uploaded
:Proof that the
manufacturer
has
manufactured
and marketed
the goods on
tender for at
least two (2)
years .
Page 5 of 243
2.6 A written
declaration to
be uploaded
from the
manufactures
or their
accredited
agents stating
whether they
have been
debarred
/disqualified
from supply by
an agency
(local and
overseas)
during the last
ten years .In
case they have
been debarred
/disqualified
/banned ,
provide name
of agency ,
period of
ineligibility and
reasons for
debarment/disq
ualification .
QUALIFICATION AND EXPERIENCE CRITERIA FOR EVALUATION
Qualification and Experience criteria for evaluation:
Sr. No. Q & E Bidder Comments from Supporting
criteria response Bidder document
1 N/A
Price Schedule B1 _ Goods manufactured outside Mauritius to be delivered at Mauritius
port of entry – Option 1 (Ver. 1.0)
Sl Ite Des Uni Qua Str Dos Qua Uni Inc Uni Tot Pha Del Bid She She Nam Sit Sou Rem
No. m cri t nti eng age nti t ote t al rma ive der lf lf e e rci ark
Cod pti of ty th For ty Pac rm Pri pri cop ry ’s lif lif and and ng s
e ons mea Req Off m off k ce ce eia Per off e e add Add Age
of sur uir ere off ere siz per per l iod ere Req Pro res res nt
Ite e ed d ere d e lin lin Sta d ues pos s s (if
ms d off e e nda Del ted ed of of any
ere ite ite rd ive Man Man )
d m m ry ufa ufa
per ctu ctu
iod rer rin
(s) g
Pla
nt
Page 6 of 243
1 CNS Alp Tab 208 CIP Wit 75

A raz 000 /AI hin to
1** ola R 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
2 (EI Bip amp 320 CIP Wit 75
THE eri 0 /AI hin to
R) den R 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
3 ( Pro amp 320 CIP Wit 75
OR cyc 0 /AI hin to
) lid R 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
Page 7 of 243
4 CNS Clo Tab 432 CIP Wit 75

A naz /Ca 00 /AI hin to
4** epa p R 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
5 CNS Clo fla 420 CIP Wit 75
A naz sk 0 /AI hin to
5** epa R 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
6 CNS Dia amp 820 CIP Wit 75
A zep 0 /AI hin to
6** am R 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 8 of 243
7 CNS Dia Tab 292 CIP Wit 75

A zep /Ca 000 /AI hin to
7** am p R 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8 CNS Erg Tab 187 CIP Wit 75
A ota /ca 500 /AI hin to
8** min p R 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 9 of 243
9 CNS Erg Tab 187 CIF Wit 75

S ota /ca 500 /SE hin to
8** min p A 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
10 CNS Flu amp 820 CIP Wit 75
A phe 0 /AI hin to
9** naz R 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
11 CNS Hal amp 250 CIP Wit 75
A ope 00 /AI hin to
10* rid R 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
Page 10 of 243
12 CNS Imi Tab 166 CIP Wit 75

A pra /Ca 500 /AI hin to
11* min p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
13 CNS Imi Tab 166 CIF Wit 75
S pra /Ca 500 /SE hin to
11* min p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 11 of 243
14 CNS Lit Tab 833 CIP Wit 75

A hiu /Ca 00 /AI hin to
12* m p R 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
15 CNS Lit Tab 833 CIF Wit 75
S hiu /Ca 00 /SE hin to
12* m p A 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 12 of 243
16 CNS Nit Tab 100 CIP Wit 75

A raz /Ca 000 /AI hin to
13* epa p R 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
17 CNS Ola Tab 125 CIP Wit 75
A nza 000 /AI hin to
14* pin R 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 13 of 243
18 CNS Ola Tab 125 CIF Wit 75

S nza 000 /SE hin to
14* pin A 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
A nza /Ca 500 /AI hin to
15* pin p R 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 14 of 243

S nza /Ca 500 /SE hin to
15* pin p A 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
21 CNS Par Tab 250 CIP Wit 75
A oxe /Ca 000 /AI hin to
16* tin p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 15 of 243
22 CNS Par Tab 250 CIF Wit 75

S oxe /Ca 000 /SE hin to
16* tin p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
23 CNS Phe amp 375 CIP Wit 75
A nyt 00 /AI hin to
17* oin R 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
24 CNS Ris tab 750 CIP Wit 75
A per 000 /AI hin to
18* ido R 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 16 of 243
25 CNS Ris tab 750 CIF Wit 75

S per 000 /SE hin to
18* ido A 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
26 CNS Ris Tab 416 CIP Wit 75
19* ido R 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 17 of 243
27 CNS Ris Tab 416 CIF Wit 75

19* ido A 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
20* ido R 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 18 of 243

20* ido A 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30 CNS Ven Tab 415 CIP Wit 75
A laf /Ca 00 /AI hin to
21* axi p R 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 19 of 243
31 CNS Ven Tab 415 CIF Wit 75

S laf /Ca 00 /SE hin to
21* axi p A 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
22* axi p R 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
22* axi p A 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 20 of 243
34 CNS Zuc amp 800 CIP Wit 75

A lop /AI hin to
23* ent R 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
A lop 0 /AI hin to
24* ent R 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 /AI hin to
25* thi R 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
Page 21 of 243
37 CNS Ami Tab 250 CIF Wit 75

S tri /Ca 000 /SE hin to
26* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
27* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
Page 22 of 243
39 CNS Chl Tab 120 CIF Wit 75

S orp /Ca 000 /SE hin to
28* rom p 0 A 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 23 of 243
40 CNS Co- Tab 100 CIF Wit 75

S Car /Ca 000 /SE hin to
29* eld p 0 A 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
41 CNS Dot Tab 190 CIF Wit 75
S hie /Ca 000 /SE hin to
30* pin p 0 A 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 24 of 243

31* pin p A 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
43 CNS Flu Tab 833 CIF Wit 75
32* tin p A 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 25 of 243
44 CNS Hal Tab 833 CIF Wit 75

S ope /Ca 300 /SE hin to
33* rid p A 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 A 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 26 of 243
46 CNS Phe Tab 125 CIF Wit 75

S nyt /Ca 000 /SE hin to
35* oin p 0 A 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
47 CNS Pro Tab 1 CIF Wit 75
S cyc /Ca ,17 /SE hin to
36* lid p 0,0 A 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 27 of 243
48 CNS Tri Tab 330 CIF Wit 75

S hex /Ca 000 /SE hin to
37* yph p 0 A 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
49 CNS Ari Tab 664 CIF Wit 75
S pip 000 /SE hin to
38* raz A 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 28 of 243

39* raz A 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p A 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 29 of 243

41* rom p A 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 30 of 243

S Ben /Ca 000 /SE hin to
42* eld p A 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
54 CNS Don Tab 125 CIF Wit 75
S epe /Ca 000 /SE hin to
43* zil p A 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 31 of 243

44* zil p A 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p A 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
d m m ry ufa ufa
per ctu ctu
iod rer rin
(s) g
Pla
nt
Page 32 of 243

1** ola R 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
R) den R 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
OR cyc 0 /AI hin to
) lid R 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
Page 33 of 243

4** epa p R 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
5** epa R 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
A zep 0 /AI hin to
6** am R 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 34 of 243

7** am p R 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p R 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 35 of 243

8** min p A 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A phe 0 /AI hin to
9** naz R 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 /AI hin to
10* rid R 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
Page 36 of 243

11* min p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
11* min p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 37 of 243

12* m p R 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
12* m p A 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 38 of 243

13* epa p R 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
14* pin R 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 39 of 243

14* pin A 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
15* pin p R 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 40 of 243

15* pin p A 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 41 of 243

16* tin p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A nyt 00 /AI hin to
17* oin R 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
18* ido R 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 42 of 243

18* ido A 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
19* ido R 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 43 of 243

19* ido A 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
20* ido R 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 44 of 243

20* ido A 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
21* axi p R 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 45 of 243

21* axi p A 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
22* axi p R 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
22* axi p A 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 46 of 243

A lop /AI hin to
23* ent R 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
A lop 0 /AI hin to
24* ent R 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 /AI hin to
25* thi R 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
Page 47 of 243

26* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
27* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
Page 48 of 243

28* rom p 0 A 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 49 of 243

29* eld p 0 A 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 A 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 50 of 243

31* pin p A 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p A 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 51 of 243

33* rid p A 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 A 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 52 of 243

35* oin p 0 A 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 A 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 53 of 243

37* yph p 0 A 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
38* raz A 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 54 of 243

39* raz A 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p A 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 55 of 243

41* rom p A 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 56 of 243

42* eld p A 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p A 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 57 of 243

44* zil p A 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p A 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
d m m ry ufa ufa
per ctu ctu
iod rer rin
(s) g
Pla
nt
Page 58 of 243

1** ola R 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
R) den R 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
OR cyc 0 /AI hin to
) lid R 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
Page 59 of 243

4** epa p R 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
5** epa R 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
A zep 0 /AI hin to
6** am R 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 60 of 243

7** am p R 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p R 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 61 of 243

8** min p A 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A phe 0 /AI hin to
9** naz R 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 /AI hin to
10* rid R 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
Page 62 of 243

11* min p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
11* min p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 63 of 243

12* m p R 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
12* m p A 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 64 of 243

13* epa p R 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
14* pin R 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 65 of 243

14* pin A 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
15* pin p R 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 66 of 243

15* pin p A 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p R 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 67 of 243

16* tin p A 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A nyt 00 /AI hin to
17* oin R 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
18* ido R 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 68 of 243

18* ido A 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
19* ido R 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 69 of 243

19* ido A 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
20* ido R 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 70 of 243

20* ido A 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
21* axi p R 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 71 of 243

21* axi p A 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
22* axi p R 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
22* axi p A 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 72 of 243

A lop /AI hin to
23* ent R 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
A lop 0 /AI hin to
24* ent R 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 /AI hin to
25* thi R 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
Page 73 of 243

26* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
27* pty p 0 A 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
Page 74 of 243

28* rom p 0 A 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 75 of 243

29* eld p 0 A 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 A 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 76 of 243

31* pin p A 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p A 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 77 of 243

33* rid p A 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 A 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 78 of 243

35* oin p 0 A 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 A 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 79 of 243

37* yph p 0 A 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
38* raz A 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 80 of 243

39* raz A 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p A 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 81 of 243

41* rom p A 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 82 of 243

42* eld p A 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p A 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 83 of 243

44* zil p A 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p A 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Schedule C1 _ Goods manufactured outside Mauritius to be delivered at warehouse
in fixed Mauritian Rupees – Option 1 (Ver. 1.0)
Price Details
Total price in MUR(Excluding VAT):
Sl Ite Des Uni Qua Str Dos Qua Uni Uni VAT Tot Pha Del Bid She She Nam Sit Sou Rem
No. m cri t nti eng age nti t t in al rma ive der lf lf e e rci ark
Cod pti of ty th For ty Pac Pri MUR pri cop ry ’s lif lif and and ng s
e ons mea Req Off m off k ce per ce eia Per off e e add Add Age
of sur uir ere off ere siz in lin in l iod ere Req Pro res res nt
Ite e ed d ere d e MUR e MUR Sta d ues pos s s (if
ms d (of per ite (Ex nda Del ted ed of of any
fer lin m clu rd ive Man Man )
ed) e din ry ufa ufa
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
ies
Page 84 of 243
and
loc
al
tra
nsp
ort
ati
on
1 CNS Alp Tab 208 Wit 75
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
2 (EI Bip amp 320 Wit 75
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 85 of 243
3 ( Pro amp 320 Wit 75

OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
4 CNS Clo Tab 432 Wit 75
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
5 CNS Clo fla 420 Wit 75
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 86 of 243
6 CNS Dia amp 820 Wit 75

A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7 CNS Dia Tab 292 Wit 75
A zep /Ca 000 hin to
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 87 of 243
8 CNS Erg Tab 187 Wit 75

A ota /ca 500 hin to
8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S ota /ca 500 hin to
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 88 of 243
10 CNS Flu amp 820 Wit 75

A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
11 CNS Hal amp 250 Wit 75
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
12 CNS Imi Tab 166 Wit 75
A pra /Ca 500 hin to
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 89 of 243

S pra /Ca 500 hin to
11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
14 CNS Lit Tab 833 Wit 75
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 90 of 243

S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
16 CNS Nit Tab 100 Wit 75
A raz /Ca 000 hin to
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 91 of 243
17 CNS Ola Tab 125 Wit 75

A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 92 of 243

A nza /Ca 500 hin to
15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S nza /Ca 500 hin to
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 93 of 243
21 CNS Par Tab 250 Wit 75

A oxe /Ca 000 hin to
16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S oxe /Ca 000 hin to
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 94 of 243
23 CNS Phe amp 375 Wit 75

A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
24 CNS Ris tab 750 Wit 75
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 95 of 243
26 CNS Ris Tab 416 Wit 75

A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 96 of 243

A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 97 of 243
30 CNS Ven Tab 415 Wit 75

A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 98 of 243

A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
34 CNS Zuc amp 800 Wit 75
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 99 of 243

A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
37 CNS Ami Tab 250 Wit 75
S tri /Ca 000 hin to
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 100 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
39 CNS Chl Tab 120 Wit 75
S orp /Ca 000 hin to
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 101 of 243

40 CNS Co- Tab 100 Wit 75

S Car /Ca 000 hin to
29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
41 CNS Dot Tab 190 Wit 75
S hie /Ca 000 hin to
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 102 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
43 CNS Flu Tab 833 Wit 75
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 103 of 243

44 CNS Hal Tab 833 Wit 75

S ope /Ca 300 hin to
33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 104 of 243

46 CNS Phe Tab 125 Wit 75

S nyt /Ca 000 hin to
35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
47 CNS Pro Tab 1 Wit 75
S cyc /Ca ,17 hin to
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 105 of 243

48 CNS Tri Tab 330 Wit 75

S hex /Ca 000 hin to
37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
49 CNS Ari Tab 664 Wit 75
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 106 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 107 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 108 of 243


S Ben /Ca 000 hin to
42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
54 CNS Don Tab 125 Wit 75
S epe /Ca 000 hin to
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 109 of 243


S epe /Ca 00 hin to
44* zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Details
Total price in MUR (Excluding
VAT):
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
Page 110 of 243

ies
and
loc
al
tra
nsp
ort
ati
on
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 111 of 243


OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 112 of 243


A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 113 of 243


8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 114 of 243


A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 115 of 243


11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 116 of 243


S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 117 of 243


A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 118 of 243


15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 119 of 243


16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 120 of 243


A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 121 of 243


A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 122 of 243


A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 123 of 243


A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 124 of 243


A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 125 of 243


A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 126 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 127 of 243


29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 128 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 129 of 243


33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 130 of 243


35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 131 of 243


37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 132 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 133 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 134 of 243


42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 135 of 243


S epe /Ca 00 hin to
44* zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Details
VAT):
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
Page 136 of 243

ies
and
loc
al
tra
nsp
ort
ati
on
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 137 of 243


OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 138 of 243


A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 139 of 243


8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 140 of 243


A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 141 of 243


11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 142 of 243


S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 143 of 243


A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 144 of 243


15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 145 of 243


16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 146 of 243


A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 147 of 243


A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 148 of 243


A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 149 of 243


A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 150 of 243


A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 151 of 243


A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 152 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 153 of 243


29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 154 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 155 of 243


33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 156 of 243


35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 157 of 243


37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 158 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 159 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 160 of 243


42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 161 of 243


S epe /Ca 00 hin to
44* zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Schedule D1 _ Goods manufactured outside Mauritius to be delivered at warehouse
in Mauritian Rupees adjustable to rate of exchange – Option 1 (Ver. 1.0)
Price Details
VAT):
Sl Ite Des Uni Qua Str Dos Qua Uni Uni VAT Tot For Exc Pha Del Bid She She Nam Sit Sou Rem
No. m cri t nti eng age nti t t in al eig han rma ive der lf lf e e rci ark
Cod pti of ty th For ty Pac Pri MUR pri n ge cop ry ’s lif lif and and ng s
e ons mea Req Off m off k ce per ce Cur Rat eia Per off e e add Add Age
of sur uir ere off ere siz in lin in ren e l iod ere Req Pro res res nt
Ite e ed d ere d e MUR e MUR cy Sta d ues pos s s (if
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
Page 162 of 243

ies
and
loc
al
tra
nsp
ort
ati
on
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 163 of 243


OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 164 of 243


A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 165 of 243


8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 166 of 243


A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 167 of 243


11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 168 of 243


S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 169 of 243


A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 170 of 243


15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 171 of 243


16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 172 of 243


A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 173 of 243


A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 174 of 243


A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 175 of 243


A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 176 of 243


A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 177 of 243


A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 178 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 179 of 243


29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 180 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 181 of 243


33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 182 of 243


35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 183 of 243


37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 184 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 185 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 186 of 243


42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 187 of 243

55 CNSDon Tab 830 Wit 75

S epe /Ca 00 hin to
44*zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Details
VAT):
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
Page 188 of 243

ies
and
loc
al
tra
nsp
ort
ati
on
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 189 of 243


OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 190 of 243


A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 191 of 243


8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 192 of 243


A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 193 of 243


11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 194 of 243


S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 195 of 243


A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 196 of 243


15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 197 of 243


16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 198 of 243


A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 199 of 243


A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 200 of 243


A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 201 of 243


A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 202 of 243


A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 203 of 243


A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 204 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 205 of 243


29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 206 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 207 of 243


33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 208 of 243


35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 209 of 243


37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 210 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 211 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 212 of 243


42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 213 of 243

55 CNSDon Tab 830 Wit 75

S epe /Ca 00 hin to
44*zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Price Details
VAT):
ite g per ctu ctu
m VAT iod rer rin
inc ) (s) g
lus Pla
ive nt
of
dut
Page 214 of 243

ies
and
loc
al
tra
nsp
ort
ati
on
A raz 000 hin to
1** ola 3 80
m mon per
0.5 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
THE eri 0 hin to
R) den 3 80
CNS Lac mon per
A tat ths cen
2** e t
Inj of
. 5 the
mg/ tot
ml al
x 1 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 215 of 243


OR cyc 0 hin to
) lid 3 80
CNS ine mon per
A3* HCL ths cen
* Inj t
. 5 of
mg/ the
ml tot
x 2 al
ml she
IM/ lf
IV lif
(In e
2
ins
tal
men
ts)
A naz /Ca 00 hin to
4** epa p 3 80
* m 2 mon per
mg ths cen
Tab t
s/ of
Cap the
s tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
A naz sk 0 hin to
5** epa 3 80
* m mon per
Dro ths cen
ps t
2.5 of
mg/ the
ml tot
x al
10 she
ml lf
(In lif
2 e
ins
tal
men
ts)
Page 216 of 243


A zep 0 hin to
6** am 3 80
* Inj mon per
. ths cen
IM/ t
IV of
5 the
mg/ tot
ml al
x 2 she
ml lf
(In lif
2 e
ins
tal
men
ts)
7** am p 3 80
5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 217 of 243


8** min p 3 80
e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
8** min p 4 80
(a) e mon per
Com ths cen
pou t
nd of
Tab the
s/C tot
aps al
(to she
dis lf
clo lif
se e
for
mul
a)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 218 of 243


A phe 0 hin to
9** naz 3 80
ine mon per
Dec ths cen
ano t
ate of
Inj the
. tot
25 al
mg/ she
ml lf
x lif
1ml e
IM
(In
2
ins
tal
men
ts)
A ope 00 hin to
10* rid 3 80
* ol mon per
Inj ths cen
. 5 t
mg/ of
ml the
x 1 tot
ml al
(In she
2 lf
ins lif
tal e
men
ts)
11* min p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
Page 219 of 243


11* min p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)
A hiu /Ca 00 hin to
12* m p 3 80
** Car mon per
bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
Page 220 of 243


S hiu /Ca 00 hin to
12* m p 4 80
** Car mon per
(a) bon ths cen
ate t
400 of
- the
450 tot
mg al
Tab she
s/C lf
aps lif
(to e
spe
cif
y
off
er)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)(
in
2
ins
tal
men
ts)
13* epa p 3 80
* m 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 221 of 243


A nza 000 hin to
14* pin 3 80
* e mon per
10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
S nza 000 hin to
14* pin 4 80
* e mon per
(a) 10 ths cen
mg t
Ora of
l the
Dis tot
per al
sib she
le lf
Tab lif
s e
Or
Mel
t
Tab
s
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
Page 222 of 243


15* pin p 3 80
* e mon per
10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
15* pin p 4 80
* e mon per
(a) 10 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 223 of 243


16* tin p 3 80
* e mon per
HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
16* tin p 4 80
* e mon per
(a) HCL ths cen
10 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 224 of 243


A nyt 00 hin to
17* oin 3 80
* Sod mon per
ium ths cen
Inj t
. of
50 the
mg/ tot
ml al
x 5 she
ml lf
IV lif
(In e
2
ins
tal
men
ts)
A per 000 hin to
18* ido 3 80
* ne mon per
1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S per 000 hin to
18* ido 4 80
* ne mon per
(a) 1 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
Page 225 of 243


A per 500 hin to
19* ido 3 80
* ne mon per
2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 500 hin to
19* ido 4 80
* ne mon per
(a) 2 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 226 of 243


A per 200 hin to
20* ido 3 80
* ne mon per
3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S per 200 hin to
20* ido 4 80
* ne mon per
(a) 3 ths cen
mg t
Tab of
s the
(sc tot
ore al
d) she
(Pr lf
efe lif
rab e
ly
in
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 227 of 243


A laf /Ca 00 hin to
21* axi p 3 80
* ne mon per
HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
S laf /Ca 00 hin to
21* axi p 4 80
* ne mon per
(a) HCL ths cen
37. t
5 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 228 of 243


A laf /Ca 00 hin to
22* axi p 3 80
* ne mon per
HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
S laf /Ca 00 hin to
22* axi p 4 80
* ne mon per
(a) HCL ths cen
75 t
mg of
XL the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
A lop hin to
23* ent 3 80
* hix mon per
ol ths cen
Ace t
tat of
e the
Inj tot
ect al
ion she
50m lf
g/m lif
l e
(In
2
ins
tal
men
ts
Page 229 of 243


A lop 0 hin to
24* ent 3 80
* hix mon per
ol ths cen
Dec t
ano of
ate the
Inj tot
ect al
ion she
200 lf
mg/ lif
ml e
(in
2
ins
tal
men
ts
)
A pen 0 hin to
25* thi 3 80
* xol mon per
Dec ths cen
ano t
ate of
20m the
g/m tot
l al
Inj she
ect lf
ion lif
(In e
2
ins
tal
men
ts
)
26* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
10 of
mg the
Tab tot
s/C al
aps she
(in lf
str lif
ip/ e
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 230 of 243


27* pty p 0 4 80
* lli mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
(In
2
ins
tal
men
ts)
28* rom p 0 4 80
* azi mon per
ne ths cen
HCL t
100 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s
up
to
100
)(I
n 2
ins
tal
men
ts)
Page 231 of 243


29* eld p 0 4 80
* opa mon per
275 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
250 lif
mg e
+
Car
bid
opa
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
30* pin p 0 4 80
* HCL mon per
25 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 232 of 243


31* pin p 4 80
* HCL mon per
75 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
32* tin p 4 80
* e mon per
20 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
3
ins
tal
men
ts)
Page 233 of 243


33* rid p 4 80
* ol mon per
1.5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
34* tin p 0 4 80
* e mon per
HCL ths cen
20 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 234 of 243


35* oin p 0 4 80
* Sod mon per
ium ths cen
100 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
36* lid p 0,0 4 80
* ine 00 mon per
HCL ths cen
5 t
mg of
Tab the
s/C tot
aps al
(Pr she
efe lf
rab lif
ly e
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 235 of 243


37* yph p 0 4 80
* eni mon per
dyl ths cen
HCL t
(Be of
nzh the
exo tot
l) al
2 she
mg lf
Tab lif
s/C e
aps
(Pr
efe
rab
ly
Str
ip/
Bli
ste
r
pac
k )
(In
2
ins
tal
men
ts)
S pip 000 hin to
38* raz 4 80
* ole mon per
5 ths cen
mg t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k)
(In
2
Ins
tal
men
ts)
Page 236 of 243


S pip 000 hin to
39* raz 4 80
* ole mon per
10m ths cen
g t
Tab of
(Pr the
efe tot
rab al
ly she
str lf
ip/ lif
bli e
ste
r
pac
k )
40* rom p 4 80
* azi mon per
ne ths cen
HCL t
25 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(in
2
ins
tal
men
ts)
Page 237 of 243


41* rom p 4 80
* azi mon per
ne ths cen
HCL t
50 of
mg the
Tab tot
s/C al
aps she
(Pr lf
efe lif
rab e
ly
str
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
Page 238 of 243


42* eld p 4 80
* opa mon per
125 ths cen
mg t
Tab of
s/C the
aps tot
(Le al
vod she
opa lf
100 lif
mg e
+
Ben
ser
azi
de
25
mg)
(Pr
efe
rab
ly
str
ip/
bli
ste
r
pac
k
or
in
box
of
loo
se
tab
s/c
aps
up
to
100
)
(In
2
ins
tal
men
ts)
43* zil p 4 80
* 10 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
Page 239 of 243


S epe /Ca 00 hin to
44* zil p 4 80
* 5 mon per
mg ths cen
Tab t
s/C of
aps the
(Pr tot
efe al
rab she
ly lf
str lif
ip/ e
bli
ste
r
pac
k)
45* rid p 4 80
* ol mon per
5 ths cen
mg t
Tab of
s/C the
aps tot
(Pr al
efe she
rab lf
ly lif
str e
ip/
bli
ste
r
pac
k)
(In
2
ins
tal
men
ts)
ANY OTHER DOCUMENTS (VER. 1.0)
Other documents: No files attached.
TECHNICAL RESPONSIVENESS CHECKLIST_UPLOAD
Technical Responsiveness Checklist: No files attached.
BID FORM_HEALTH SECTOR GOODS (VER. 1.0)
Name of Contract: PROCUREMENT OF DRUGS USED FOR CENTRAL
NERVOUS SYSTEM (ANNUAL REQUIREMENT)
MHPQ/PHARM/2022-2023/Q 37 OIB
Name and Address of Purchaser: The Senior Chief Executive Ministry of
Health & Wellness 10th Floor Emmanuel
Anquetil Building, SSR Street Port Louis
Mauritius
Dear Sir or Madam:(a)We have examined and have no reservations to the Bidding
Documents, including any addendum issued in accordance to Instructions to Bidders (ITB
18.1).:
(b)We the undersigned, offer to supply and deliver the goods under the above-named
contract in full conformity with the Bidding Documents at the sum of ::
(i) Bid Price for goods manufactured outside Mauritius_Option 1:
Amount in figures for Option 1 Item Reference
(ii) Bid price for goods manufactured outside Mauritius_Option 2 (at Bidder’s option,
Page 240 of 243
where allowed):
(iii) Bid price for goods manufactured outside Mauritius_Option 3 (at Bidder’s option,
where allowed):
(hereinafter called “the Total Bid Price”) or such other sums as may be determined in
accordance with the terms and conditions of the Contract. The above amounts are in
accordance with the Price Schedules attached herewith and are made part of this bid.:
(c) We undertake, if our bid is accepted, to deliver the Goods in accordance with the
delivery schedule specified in the Schedule of Requirements.(d)We agree to abide by
this bid, for the Bid Validity Period specified in Clause 18.1 of the Bid Data Sheet
and it shall remain binding upon us and may be accepted by you at any time before the
expiration of that period:
(e)If our bid is accepted, we undertake to provide, if so specified, an advance
payment security and a Performance Security in the form, in the amounts, and within
the times specified in the Bidding Documents.:
(f) Commissions or gratuities, if any, paid or to be paid by us to agents relating to
this bid, and to contract execution if we are awarded the Contract, are listed
below:(if none, state “none”):
Commissions or Gratuities:
Name and Address of Agent Amount and Currency Purpose of Commission or
Gratuity
(g) We hereby confirm that we have read and understood the content of the Bid Securing
Declaration attached hereunder and subscribe fully to the terms and conditions
contained therein, if a Bid Securing Declaration is required. We understand that non-
compliance to the conditions mentioned may lead to disqualification.:
(h) We are hereby submitting copy of our Bid Security, if so required by the procuring
entity, in lieu of the Bid Securing Declaration.:
(i)We have taken steps to ensure that no person acting for us or on our behalf will
engage in any type of fraud and corruption as per the principles described hereunder,
during the bidding process and contract execution:i.We shall not, directly or through
any other person or firm, offer, promise or give to any of the Purchaser’s employees
involved in the bidding process or the execution of the contract or to any third
person any material or immaterial benefit which he/she is not legally entitled to, in
order to obtain in exchange any advantage of any kind whatsoever during the tender
process or during the execution of the contract.ii.We shall not enter with other
Bidders into any undisclosed agreement or understanding, whether formal or informal.
This applies in particular to prices, specifications, certifications, subsidiary
contracts, submission or non-submission of bids or any other actions to restrict
competitiveness or to introduce cartelisation in the bidding process.iii.We shall not
use falsified documents, erroneous data or deliberately not disclose requested facts
to obtain a benefit in a procurement proceeding. We understand that transgression of
the above is a serious offence and appropriate actions will be taken against such
bidders.:
(j) Until the formal final Contract is prepared and executed between us, this bid,
together with your written acceptance of the bid and your notification of award, shall
constitute a binding Contract between us. (k)We understand that you are not bound to
accept the lowest or any bid you may receive.:
Name of Person duly authorized to
digitally signing the bid:
In the capacity of:
Duly authorized to digitally sign the bid
for and on behalf of::
Page 241 of 243

Bid Securing DeclarationBy subscribing to the undertaking in respect of paragraph (g)

of the Bid Submission Form: I/We accept that I/we may be disqualified from bidding for
any contract with any Public Body for the period of time that may be determined by the
Procurement Policy Office under section 35 of the Public Procurement Act, if I am/we
are* in breach of any obligation under the bid conditions, because I/we:(a) have
modified or withdrawn my/our Bid after the deadline for submission of bids during the
period of bid validity specified by the Bidder in the Bid Submission Form; or(b) have
refused to accept a correction of an error appearing on the face of the Bid; or(c)
having been notified of the acceptance of our Bid by the public body during the period
of bid validity, (i) have failed or refused to execute the Contract, if required,
or (ii) have failed or refused to furnish the Performance Security, in accordance
with the Instructions to Bidders. I/We understand this Bid Securing Declaration shall
cease to be valid (a) in case I/we am/are the successful bidder, upon our receipt of
copies of the contract signed by you and the Performance Security issued to you by
me/us ; or (b) if I am/we are not the successful Bidder, upon the earlier of (i) the
receipt of your notification of the name of the successful Bidder; or (ii) thirty days
after the expiration of the validity of my/our Bid. In case of a Joint Venture, all
the partners of the Joint Venture shall be jointly and severally liable.:
Page 242 of 243

Invitation for Bid Name: PROCUREMENT OF DRUGS USED FOR CENTRAL NERVOUS SYSTEM (ANNUAL REQUIREMENT) MHPQ/PHARM/2022-2023/Q 37
OIB
Page 243 of 243

Procurement of Drugs Used For Central Nervous System (Annual Requirement) MHPQ - Pharm - 2022-2023 - Q 37 Oib-Health - Ifb - 2022 - 928

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Procurement of Drugs Used For Central Nervous System (Annual Requirement) MHPQ - Pharm - 2022-2023 - Q 37 Oib-Health - Ifb - 2022 - 928

Uploaded by

Copyright:

Available Formats

Government of Mauritius e-Procurement System

Government of Mauritius e-Procurement System

Procurement Request reference: MHPQ/PHARM/2022-2023/Q 37 OIB

Bid Submission Fees: No Payment

Validity of Bids: 120 DAYS

PROCUREMENT OF DRUGS USED FOR CENTRAL NERVOUS SYSTEM(ANNUAL REQUIREMENT)

REMARKS FOR CANCELLATION AUTHORITY

TECHNICAL CRITERIA FOR EVALUATION

1 CNS Alp Tab 208 CIP Wit 75

4 CNS Clo Tab 432 CIP Wit 75

7 CNS Dia Tab 292 CIP Wit 75

9 CNS Erg Tab 187 CIF Wit 75

12 CNS Imi Tab 166 CIP Wit 75

14 CNS Lit Tab 833 CIP Wit 75

16 CNS Nit Tab 100 CIP Wit 75

18 CNS Ola Tab 125 CIF Wit 75

20 CNS Ola Tab 666 CIF Wit 75

22 CNS Par Tab 250 CIF Wit 75

25 CNS Ris tab 750 CIF Wit 75

27 CNS Ris Tab 416 CIF Wit 75

29 CNS Ris Tab 333 CIF Wit 75

31 CNS Ven Tab 415 CIF Wit 75

34 CNS Zuc amp 800 CIP Wit 75

37 CNS Ami Tab 250 CIF Wit 75

39 CNS Chl Tab 120 CIF Wit 75

40 CNS Co- Tab 100 CIF Wit 75

42 CNS Dot Tab 750 CIF Wit 75

44 CNS Hal Tab 833 CIF Wit 75

46 CNS Phe Tab 125 CIF Wit 75

48 CNS Tri Tab 330 CIF Wit 75

50 CNS Ari Tab 664 CIF Wit 75

52 CNS Chl Tab 209 CIF Wit 75

53 CNS Co- Tab 333 CIF Wit 75

55 CNS Don Tab 830 CIF Wit 75

1 CNS Alp Tab 208 CIP Wit 75

4 CNS Clo Tab 432 CIP Wit 75

7 CNS Dia Tab 292 CIP Wit 75

9 CNS Erg Tab 187 CIF Wit 75

12 CNS Imi Tab 166 CIP Wit 75

14 CNS Lit Tab 833 CIP Wit 75

16 CNS Nit Tab 100 CIP Wit 75

18 CNS Ola Tab 125 CIF Wit 75

20 CNS Ola Tab 666 CIF Wit 75

22 CNS Par Tab 250 CIF Wit 75

25 CNS Ris tab 750 CIF Wit 75

27 CNS Ris Tab 416 CIF Wit 75

29 CNS Ris Tab 333 CIF Wit 75

31 CNS Ven Tab 415 CIF Wit 75

34 CNS Zuc amp 800 CIP Wit 75

37 CNS Ami Tab 250 CIF Wit 75

39 CNS Chl Tab 120 CIF Wit 75

40 CNS Co- Tab 100 CIF Wit 75

42 CNS Dot Tab 750 CIF Wit 75

44 CNS Hal Tab 833 CIF Wit 75

46 CNS Phe Tab 125 CIF Wit 75

48 CNS Tri Tab 330 CIF Wit 75

50 CNS Ari Tab 664 CIF Wit 75

52 CNS Chl Tab 209 CIF Wit 75

53 CNS Co- Tab 333 CIF Wit 75

55 CNS Don Tab 830 CIF Wit 75

1 CNS Alp Tab 208 CIP Wit 75

4 CNS Clo Tab 432 CIP Wit 75

7 CNS Dia Tab 292 CIP Wit 75